Description
BSE listing details for new equity shares of Novelix Pharmaceuticals Limited with lock-in periods.
Summary
BSE has listed new equity shares of NOVELIX PHARMACEUTICALS LIMITED with detailed allocation information including distinctive numbers and lock-in end dates.
Key Points
- Total of 19 different allocations of equity shares listed
- Share allocations range from 10,000 to 15,00,000 equity shares
- Distinctive numbers assigned from 9950001 to 12935000
- Lock-in periods vary with most ending on 30/03/2026 and 31/03/2026
- One allocation has extended lock-in period until 30/03/2027
Regulatory Changes
No regulatory changes specified in this listing circular.
Compliance Requirements
- Shareholders must comply with lock-in period restrictions
- Trading of these securities will be restricted until respective lock-in end dates
Important Dates
- Lock-in End Dates: 30/03/2026 and 31/03/2026 for most allocations
- Extended Lock-in: 30/03/2027 for first allocation of 2,00,000 shares
Impact Assessment
Medium impact on company’s shareholding structure with significant number of new shares being listed. Lock-in periods provide stability by preventing immediate trading of these securities.
Impact Justification
Standard new securities listing with defined lock-in periods affects shareholding structure